Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
KNF’s RC900 Rotary Evaporator Proves Popular at Oxford
Thursday, November 20, 2014
System is designed to make attaching and detaching the round bottom flask simple.

New Precision Balances: Reliable, Compliant and Intuitive
Monday, November 03, 2014
METTLER TOLEDO's Excellence XPE precision balances make daily weighing tasks fast, easy and error-free.

New Biotage® SNAP ULTRA C18 Cartridges
Friday, October 31, 2014
High performance reversed phase flash purification cartridges and samplets.

Nagoya University’s ITbM, Japan, Licenses Cresset’s Forge
Thursday, October 30, 2014
ITbM licenses Cresset’s computational chemistry software to accelerate their research.

Consistent Consumable Quality Improves CHN Microanalysis Results
Wednesday, October 29, 2014
Company has established in-house systems to monitor and ensure the consistent, high quality of its consumables.

Reproducible Medium Throughput Compound Screening
Monday, October 27, 2014
INTEGRA reports on how Pulmocide Ltd. are using a VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays.

Versatile Evaporator for Lab & Batch Processing Tasks
Friday, October 17, 2014
New Rocket Synergy series offers automated evaporation of a wide range of sample formats and sizes.

Optibrium Introduces the Latest Release of StarDrop™
Wednesday, October 15, 2014
StarDrop 6.0 gives researchers the freedom to explore and organise complex project data in a flexible and intuitive way.

Improving the Consistency & Efficiency of Early Drug Discovery
Wednesday, October 15, 2014
Consistency and efficiency of assays improved by using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1277
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv